Trophic ulcer ICD code. Causes and treatment of trophic ulcers on the leg. Not classified in other sections

02.10.2020 Complications

Against the background of blood circulation disorders, the surface of the lower extremities is covered by an purulent wounds. They deliver pain, prevent full-fledged life, and are also able to lead to human death. What reasons provoke the appearance of such a disease? How to treat such ulcers?

Types of illness

Trophic ulcers are made to the International Classifier of Diseases of the 10th Review Code of the ICD 10. In the appropriate section there is a sequence number of the ICD 10 code L 98.4.2. The disease is a chronic damage to the skin. Based on the reasons provoked by the formation of purulent wounds, other codes are distinguished. If such formations arose as a result varicose expansion veins, then in the classifier specified code on the ICD 10 i83.0. But varicose veins, with ulcers and inflammation, is listed under a different code - I83.2. Distinguish the following types of ulcers:

Venous. Such formations are formed as a result of varicose insufficiency. In case of untimely treatment, complications may develop in the form of elephants of the leg, sepsis.
Arterial. In the result of obliterating atherosclerosis, purulent education arise, which are most often diagnosed in the elderly.
Diabetic. It is the result of complication of diabetes.
Neurotrophic. In case of injuries of the spine and head on the side surface of the heel or the sole of the legs are formed with gearboxes. The bottom of the ulcers is bone or tendon.
Hypertensive (Marorellla). People S. high pressure Papulas appear on the surface of the skin, which eventually develop in ulcers. For this type of disease, symmetry is characterized, so such wounds are formed immediately on two limbs at the same time.
Infectious (pyrogen). Penetration of infection in the body against the background of reduced immunity can lead to ulcerative formations.

Important! Each type of ulcer disease has its own code on the ICD 10.

The reasons

There are many negative factors that can become a starting mechanism for the development of the disease. Trophic ulcers of the lower extremities have a number of reasons:

chronic varicose veins;
lymph outflow violations;
excess weight;
tumors and cysts;
diabetes;
disease arteries of legs;
lesions of the skin as a result of the effects of chemical drugs or burn;
failure of an autoimmune system;
problems with heart, kidneys and liver;
defeat brain, as well as nerve fibers.

Symptoms

For high-quality treatment, it is important to diagnose the disease on time. Therefore, it should be closely followed by the status of the legs. The trophic ulcers of the lower limbs have the following manifestations:

tissue swelling;
periodic spasms;
pain;
the appearance of the vascular grid;
thinning of the skin;
hematoma formation;
increased skin temperature of the affected area;
pigmentation;
flaking soft tissues;
the appearance of the skin of the skin and the feeling of tension;
lymph output outward;
disposal of the layer of epidermis;
muka cluster.

Important! With regular manifestation painful sensations, as well as swelling in the field of ICR and the heads, should be inspected by the doctor. This will exclude the likelihood of the development of complications.

Diagnostics

To make a diagnosis of a purulent disease, you will need to make a number of surveys and analyzes:

measurement of sugar levels;
blood and urine study;
bacteriological and cytological examination;
renowmography;
vasserman reaction;
doppler:
reopletismography;
phlebography;
infrared thermography.

Treatment

After identifying the reasons that led to the pope of the foot, the legs or the calf muscle, the treatment method is selected. In the fight against the problem, several methods are used: surgical and drug. Medical therapy is aimed primarily to clean the ulcerations from pus and dead tissue particles. For this use antiseptic agents, as well as drugs to improve the scarring of wounds and cell regeneration. Medications are also applied to:

normalization of blood circulation and trophic;
reduce the risk of bacterial damage;
kill pain;
accelerate the process of healing of the skin.

Antibiotics prescribed the patient wide spectrum Actions, anti-inflammatory drugs, as well as antiallergic agents. If after conservative method The treatment of the trophic ulcer of the leg or foot does not stop its development, then the doctor recommends to conduct an intersection of the affected fabric sites. The following surgical procedures are applicable:

Vacuuming and Curetzh.
VAC therapy. The problem areas affect low negative pressure using polyurethane spongy dressings. Such therapy allows you to create a wet medium in the wound, which leads to an improvement in the state.
Virtual amputation. This method Apply with neurotrophic ulcers. Plyusnelangovaya joint and bone are removed. At the same time, the stop retains its anatomical appearance.
Katerization. The operation is applicable when the patient is diagnosed with non-visible venous, hypertensive trophic ulcers of the lower extremities.
Freshing venous arterial fistula through the skin.

In the case of chronic ulcerative formations, some patients require skin plastic, which lies in the attachment of the skin flap on the lesion area. Thanks to such an operation, rapid recovery is achieved due to a peculiar stimulator for the restoration of tissues around the wound. The following physiotherapy treatments are recommended to enhance the effectiveness of treatment:

low frequency sound cavitation. Helps increase the effect of antiseptics and antibiotics on microorganisms inside the wound;
laser therapy. Helps to reduce the painful sensations and stimulation of cell regeneration;
magnetotherapy. Has a vasodilatory and anti-ethnic effect;
ultraviolet irradiation - to improve local immunity;
balneotherapy.

During treatment and recovery, it is recommended to apply compression bandages. The limb is wounded by several layers of an elastic bandage that must be removed every night, and in the morning it is clean. Due to such compression, the swelling and the diameter of the veins decrease, and the normal blood circulation and lymphatic radiation is reduced.

Due to the large number of etiological factors that can lead to the development of the necrotic process, the code of trophic ulcers can be in different categories.

The essence of the pathological process is in violation of innervation and blood supply to a certain area of \u200b\u200bthe skin, which is accompanied by atrophic, and then necrotic changes in soft tissues.

General principle of encoding

The trophic ulcerative defect is located in the class of diseases of the skin and subcutaneous fatty tissue. The disease belongs to the heading of other pathological conditions of the skin, which is explained by the diversity of the origin of the problem. The encoding is as follows: L98.4. These characters are decoded as follows: a peptic defect that is not classified in other categories on the etiological factor.

Very often, skin defects may arise due to a long stay in a medical hospital or with long-term treatment of any pathology requiring strict beddown. Such ulcers are called prladen and concern most often the elderly. Putting in the ICD 10 are encoded as follows: L89, that is, a decabital ulcerative defect. This also includes trophic disorders caused by the squeezing of the site with a gypsum bandage or something else.

Ulcer with varicose veins

Varicose veins implies stagnation blood in the sections of weakening the venous wall. There is a problem on the lower limbs, which without proper treatment leads to the formation of ulcerative defects. In this case, the diagnosis of ulcers has a specific etiological factor, and therefore the MCB pathology will be located in the class of circulatory diseases and the heading of veins diseases. The trophic tibia ulcer and other localization can have two encoding options:

I0 - expansion of the veins of a varicose nature with the formation of a ulcerative defect;
I2 - varicose veins of the lower extremities with a peptic complication and the presence of an inflammatory process (phlebitis).

It is possible to avoid the formation of a skin defect using timely appeal to a qualified technician and adequate diagnosis and treatment.

Diabetes as a cause of trophic ulcers

Sugar diabetes is a systemic pathology leading to the damage to a large number of organs and systems. However, there are structures in the human body, the function of which is violated in the first place. Such authorities include arteries in which blood circulation is disturbed. The accompanying factor in the formation of a ulcer defect with diabetes is atherosclerosis.

However, the trophic ulcer in the ICD 10 has a code independent of this disease. To clarify availability diabetic foot In the formulation of diagnosis of diabetes, it is necessary to put additional code, as this state is not a manifestation of the disease, but its serious complication.

Class XII. Skin disease and subcutaneous tissue (L00-L99)

This class contains the following blocks:
L00.-L04. Skin and subcutaneous infection
L10-L14 Bullous disorders
L20.-L30 Dermatitis and eczema
L40.-L45 Papillovyovy violations
L50.-L54. Harfish and Erythema
L55-L59. Diseases of the skin and subcutaneous fiber associated with radiation
L60.-L75 Diseases of skin appendages
L80.-L99 Other diseases of the skin and subcutaneous fiber

An asterisk marked the following categories:
L14* Bullous skin disorders for diseases classified in other categories
L45* Papillosovy disorders in diseases classified in other categories

L54.* Erythema for diseases classified in other categories
L62.* Changes for nails in diseases classified in other categories
L86.* Ceratodermia in diseases classified in other categories
L99* Other skin disorders and subcutaneous tissue in diseases classified in other categories

Skin and subcutaneous infection (L00-L08)

If necessary, identify infectious agent use additional code ( B95-B97.).

Excluded: GORDEOLUM ( H00.0.)
Infectious dermatitis ( L30.3.)
Local skin infections classified in class I,
such as the:
ryg ( A46.)
eritisipeloid ( A26.. -)
herpety viral infection (B00. -)
anogenital ( A60.. -)
contaching mollusk ( B08.1.)
mycoses ( B35-B49.)
pediculose, Acariasis and other infestations ( B85.-B89.)
viral warts ( B07.)
Pannaculit:
BDU ( M79.3.)
lupus ( L93.2.)
neck and backs ( M54.0.)
recurrent [Weber-chrischene] ( M35.6.)
Fragment of lip spikes [Zapia] (due to):
BDU ( K13.0.)
candidiasis ( B37.. -)
riboflavina deficiency ( E53.0.)
Pyiogenic granuloma ( L98.0.)
Lishe Shing ( B02.. -)

L00 syndrome of staphylococcal skin lesions in the form of burn-like bubbles

Bubble of a newborn
Ritter disease
Excluded: toxic epidermal necroliz [Lyleel] ( L51.2.)

L01 impetigo

Excluded: impetigo herpetyiform ( L40.1.)
Bubble newborn ( L00.)

L01.0. Impetigo [caused by any organism] [any localization]. Impugi Bokharti.
L01.1 Impetigizing other dermatosis

L02 leather abscess, furuncle and carbuncoon

Included: Furuncul
furunculosis
Excluded: Area rear Passage and rectum ( K61.. -)
genital organs (outdoor):
female ( N76.4.)
male ( N48.2., N49. -)

L02.0. Abscess skin, furuncle and carbuncoon
Excluded: Outdoor Ear ( H60.0.)
century ( H00.0.)
Heads [any part, except for the face] ( L02.8.)
Temae:
glands ( H04.0.)
ways ( H04.3.)
mouth ( K12.2.)
nose ( J34.0.)
Elets ( H05.0.)
submandibular ( K12.2.)
L02.1. Abscess skin, furuncle and carbuncoon neck

L02.2. Abscess of the skin, furuncle and carbuncoon torso. Abdominal wall. Backs [any part, except butodic]. Breast wall. Groove region. Crotch. Navel
Excluded: breast ( N61.)
pelvic belt ( L02.4.)
Ommalitis of the newborn ( P38.)
L02.3. Abscess of the skin, furuncle and carbuncoon buttocks. Jagged region
Excended: Pilonidal cyst with abscess ( L05.0.)
L02.4. Abscess leather, furuncle and carbuncoon limbs
L02.8. Abscess of the skin, furuncle and carbuncoon of other localizations
L02.9. Abscess of the skin, furuncle and carbuncoon of unspecified localization. Furunculese BDA

L03 phlegmon

Included: acute lymphangitis
Excelves: Flegmon:
area of \u200b\u200bthe rear pass and rectum ( K61.. -)
external auditory pass ( H60.1.)
outdoor genital organs:
female ( N76.4.)
male ( N48.2., N49. -)
century ( H00.0.)
tear apparatus ( H04.3.)
mouth ( K12.2.)
nose ( J34.0.)
Eosinophilic cellulite [Velice] ( L98.3.)
Febrile (acute) neutrophilic dermatosis [retinue] ( L98.2.)
lymphangit (chronic) (subacute) ( I89.1)

L03.0. Phlegmon fingertips brush and foot
Nail infection. Onyhia. Paronichia. Perionic
L03.1. Phlegmon other limbs
Middleweed. Pelvic belt. Shoulder
L03.2. Phlegmon face
L03.3. Phlegmon torso. Belly walls. Backs [any part]. Breast wall. Paho. Crotch. Navel
Excluded: Newborn Ommalitis ( P38.)
L03.8. Flegmon other localization
Heads [any part, except for the face]. Misselting of the head
L03.9. Flegmon uncomfortable

L04 Acute lymphadenitis

Included: abscess (acute)) any lymphatic node,
lymphadenitis sharp) besides mesenter
Excluded: Increase lymph nodes (R59.. -)
disease caused by human immunodeficiency virus
[HIV] manifested in the form of generalized
lymphadenopathy ( B23.1.)
Lymphadenitis:
BDU ( I88.9.)
chronic or subacute, except for mesenteric ( I88.1)
mesenter nonspecific ( I88.0.)

L04.0. Acute lymphadenitis Persons, heads and necks
L04.1. Acute lymphadenitis torso
L04.2. Acute lymphadenitis of the upper limb. Middleweed. Shoulder
L04.3. Acute lymphadenitis of the lower limb. Pelvic belt
L04.8. Acute lymphadenitis of other localization
L04.9. Acute lymphadenitis uncomfortable

L05 Pilonidal cyst

Included: fistula) smokychik (aya) or
Pitza) Pilonidal (Aya)

L05.0. Pilonidal cyst with abscess
L05.9 Pilonidal cyst without abscesses. Pilonidal cyst BDA

L08 Other local skin infections and subcutaneous fiber

L08.0. PODERMIA
Dermatitis:
purulent
septic
gnotted
Excluded: Hangrenous piederma ( L88.)
L08.1. Erytrazm
L08.8. Other refined local skin infections and subcutaneous fiber
L08.9. Local skin and subcutaneous infection infective infection

Bullous disorders (L10-L14)

Excluded: benign (chronic) family pemphigus
[Haley Haley's disease] ( Q82.8.)
Staphylococcal lesion syndrome in the form of burn-like bubbles ( L00.)
Toxic epidermal necrolis [Layella syndrome] ( L51.2.)

L10 bubble [pemphigus]

Excluded: bubble newborn ( L00.)

L10.0. Bubble ordinary
L10.1. Bubble Vegetable
L10.2. Listovid bubble
L10.3. Brazilian bubble
L10.4. Bubbler erythematous. Senira Asher Syndrome
L10.5. Drug bubbles
L10.8. Other types of bubbles
L10.9 Uncomfortable bubble

L11 Other acantolytic disorders

L11.0. Acquired follicular keratosis
Excluded: Ceratosis Follicular (congenital) [Darya White] ( Q82.8.)
L11.1 Protecting acantolytic dermatosis [Grovera]
L11.8. Other refined acantolytic changes
L11.9. Akantolytic changes are unspecified

L12 pemphigoid

Excelred: herpes of pregnant women ( O26.4.)
Herpetyform impetigo ( L40.1.)

L12.0 Bullous pemphigoid
L12.1. Raying pemphigoid. Benign pemphigoid mucous membranes [lever]
L12.2. Chronic bullous disease in children. Youth herpesiform dermatitis
L12.3. Acquired bullous epidermolysis
Excluded: Bullous epidermolysis (congenital) ( Q81.. -)
L12.8. Another pemphigiod
L12.9. Pepperfigoid is unspecified

L13 Other Bull Changes

L13.0. Dermatitis herpetyform. Dorring disease
L13.1. Subcornal pustling dermatitis. Saddon-Wilkinson's disease
L13.8. Other refined bullous changes
L13.9. Bullous changes uncomfortable

L14 * Bullous skin disorders for diseases classified in other categories

Dermatitis and eczema (L20-L30)

Notes of this block, the terms "dermatitis" and "eczema" are used as interchangeable synonyms.
Excluded: chronic (children's) granulomatous disease ( D71)
dermatitis:
dry skin ( L85.3.)
artificial ( L98.1)
gangrenoz ( L88.)
herpetyform ( L13.0.)
periioral ( L71.0.)
stagnant I.83.1 — I.83.2 )
Diseases of the skin and subcutaneous fiber associated with the effect of radiation ( L55-L59.)

L20 Atopic dermatitis

Excluded: limited neurodermatitis ( L28.0.)

L20.0. Scratching Beancy
L20.8. Other atopic dermatitis
Eczema:
flexible NDCR
children's (acute) (chronic)
endogenous (allergic)
Neurodermatitis:
atopic (localized)
diffuse
L20.9 Atopic dermatitis Unclean

L21 Seborinic dermatitis

Excluded: infectious dermatitis ( L30.3.)

L21.0. Seborrhea head. "Because of the Baby"
L21.1 Seborine Children's dermatitis
L21.8. Another seborrheic dermatitis
L21.9. Seborrheic dermatitis uncomfortable

L22 diaper dermatitis

Diaper:
erythema
rash
Psoriazo-like rash caused by diapers

L23 Allergic Contact Dermatitis

Included: Allergic contact eczema
Excluded: Allergy BDU ( T78.4.)
dermatitis:
BDU ( L30.9.)
contact BDU ( L25.9)
diaper ( L22.)
L27. -)
century ( H01.1)
simple irritable contact ( L24.. -)
periioral ( L71.0.)
Eczema outdoor ear ( H60.5.)
Skin diseases and subcutaneous fiber associated with radiation exposure ( L55-L59.)

L23.0. Allergic contact dermatitis caused by metals. Chrome. Nickel
L23.1. Allergic contact dermatitis caused by sticky substances
L23.2. Allergic contact dermatitis caused by cosmetic means
L23.3. Allergic contact dermatitis caused by drugs during their skin contact
If necessary, identify the drug use additional code external reasons (Class XX).
T88.7)
L27.0.-L27.1)
L23.4. Allergic contact dermatitis caused by dyes
L23.5. Allergic contact dermatitis caused by other chemicals
Cement. Insecticides. Plastic. Rubber

L23.6. Allergic contact dermatitis caused by food products when they are pin with skin
L27.2.)
L23.7 Allergic contact dermatitis caused by plants except food
L23.8. Allergic contact dermatitis caused by other substances
L23.9 Allergic contact dermatitis, the reason is not specified. Allergic contact eczema BDU

L24 simple irritable contact dermatitis

Enabled: Simple irritant contact eczema
Excluded: Allergy BDU ( T78.4.)
dermatitis:
BDU ( L30.9.)
allergic pin ( L23. -)
contact BDU ( L25.9)
diaper ( L22.)
caused by substances accepted inside ( L27. -)
century ( H01.1)
periioral ( L71.0.)
Eczema outdoor ear ( H60.5.)
Skin disease and subcutaneous fiber associated
with radiation exposure ( L55-L59.)

L24.0. Simple irritable contact dermatitis caused by detergent
L24.1. Simple irritable contact dermatitis caused by oils and lubricants
L24.2. Simple irritable contact dermatitis caused by solvents
Solvents:
chlorine-containing)
cyclohexane)
essential)
glycolic) Group
hydrocarbon)
ketone)
L24.3. Simple irritable contact dermatitis caused by cosmetics
L24.4. Irritable contact dermatitis caused by drugs when they contact their skin
If necessary, identify the drug use additional external reasons (class XX).
Excluded: Allergies BDU caused by drugs ( T88.7)
dermatitis caused by reception medicines (L27.0.-L27.1)
L24.5. Simple irritable contact dermatitis caused by other chemicals
Cement. Insecticides
L24.6. Simple irritable contact dermatitis caused by food with their skin contact
Excluded: dermatitis caused by eaten food ( L27.2.)
L24.7 Simple irritable contact dermatitis caused by plants other than food
L24.8. Simple irritable contact dermatitis caused by other substances. Dyes
L24.9 Simple irritable contact dermatitis, the reason is not specified. Irritation contact eczema BDU

L25 Contact Dermatitis Uncomfortable

Included: Contact Eczema Uncomfortable
Excluded: Allergy BDU ( T78.4.)
dermatitis:
BDU ( L30.9.)
allergic pin ( L23. -)
caused by substances accepted inside ( L27. -)
century ( H01.1)
simple irritable contact ( L24.. -)
periioral ( L71.0.)
Eczema outdoor ear ( H60.5.)
lesions of the skin and subcutaneous fiber associated
with radiation exposure ( L55-L59.)

L25.0. Uncomfortable contact dermatitis caused by cosmetics
L25.1 Uncomfortable contact dermatitis caused by drugs when they contact them with skin
If necessary, identify the drug use additional external reasons (class XX).
Excluded: Allergies BDU caused by drugs ( T88.7)
dermatitis caused by drug intake ( L27.0.-L27.1)
L25.2. Uncomfortable contact dermatitis caused by dyes
L25.3. Uncomfortable contact dermatitis caused by other chemicals. Cement. Insecticides
L25.4. Uncomfortable contact dermatitis caused by food with skin contact with skin
Excluded: contact dermatitis caused by eaten food ( L27.2.)
L25.5. Uncomfortable contact dermatitis caused by plants, except food
L25.8. Uncomfortable contact dermatitis caused by other substances
L25.9 Uncomfortable contact dermatitis, the reason is not specified
Contact (AA):
dermatitis (Professional) BDU
eczema (Professional) BD

L26 exfoliative dermatitis

Pitiriasis Gebra
Excluded: Ritter disease ( L00.)

L27 dermatitis caused by substances accepted inside

Excluded: unfavorable (Aya):
the impact of medicines BDU ( T88.7)
food reaction, excluding dermatitis ( T78.0.-T78.1.)
allergic reaction BDU ( T78.4.)
Contact dermatitis ( L23-l25)
Drug:
photo allergic reaction ( L56.1.)
phototoxic reaction ( L56.0.)
Urban ( L50.. -)

L27.0. Generalized skin rash caused by drugs and medicines
If necessary, identify the drug use additional external reasons (class XX).
L27.1 Localized skin rash caused by drugs and medicines
If necessary, identify the drug use additional external reasons (class XX).
L27.2. Dermatitis caused by eaten food
Excluded: dermatitis caused by food products when they contact with skin ( L23.6., L24.6., L25.4.)
L27.8. Dermatitis caused by other substances accepted
L27.9. Dermatitis caused by unspecified substances accepted inside

L28 simple chronic deprived and scratch

L28.0. Simple chronic deprived. Limited neurodermatitis. Lishe BDA
L28.1. Scrabble scorching
L28.2. Other scratch
Scratch:
BDA
Gebra
mitis.
Papulse wrapper

L29 itch

Excluded: neurotic skin combing ( L98.1)
psychogenic itching ( F45.8.)

L29.0. Top Passing
L29.1. Itching midges
L29.2. Itching vulva
L29.3. Anogenital itching is uncomfortable
L29.8. Other itch
L29.9. Itching is unspecified. Itching BDA

L30 Other dermatitis

Excluded: dermatitis:
contact ( L23-L25)
dry skin ( L85.3.)
Small Parappsoriasis ( L41.3.)
Stagnant dermatitis ( I83.1-I83.2.)

L30.0. Coin eczema
L30.1. Dishydrosis [Pomfolix]
L30.2. Skin autosensitization. Candidose. Dermatofitosis. Eczematosis
L30.3. Infectious dermatitis
Infectious eczema
L30.4. Erythematous Toughness
L30.5. Pitiriasis White
L30.8. Another refined dermatitis
L30.9. Dermatitis uncomfortable
Eczema BDA

Papillosovy disorders (L40-L45)

L40 psoriasis

L40.0. Ordinary psoriasis. Coin psoriasis. Plant
L40.1. Generalized Pustulus Psoriasis. Impetigo herpetyiform. Tsumbush's disease
L40.2. Akrodmetmatitis resistant [ALLOPO]
L40.3. Pustulose palm and solebed
L40.4. Psoriasis is dropped
L40.5.+ Psoriasis Arthropathic ( M07.0.-M07.3.*, M09.0.*)
L40.8. Another psoriasis. Flexing inverse psoriasis
L40.9 Psoriasis is unspecified

L41 Parappsoriasis

Excluded: Atrophic vascular cachelodermia ( L94.5.)

L41.0. Pitiriasis Lichhenoid and axle acute. Herberman's Mukh
L41.1 Pitiriasis Lichhenoid Chronic
L41.2. Lymphomatoid papulez
L41.3. Small passing parapsoriasis
L41.4. Large Parappsoriasis
L41.5. Network parapsoriasis
L41.8. Another parapsoriasis
L41.9. Parappsoriasis is unclean

L42 Pink Pink [Zibera]

L43 deprived red flat

Excluded: deprive flat hair ( L66.1.)

L43.0. Deprive hypertrophic red flat
L43.1. Deprive red flat bullous
L43.2. Digid-shaped drug reaction
If necessary, identify the drug use additional external reasons (class XX).
L43.3. Lained red flat subacute (active). Lishe red flat tropical
L43.8. Other red flat deprived
L43.9. Deprive red flat uncomfortable

L44 Other PapilClosen Changes

L44.0. Pitiriasis red hair-shaped
L44.1. Lichni brilliant
L44.2. Linene Linene
L44.3. Lained red moniliform
L44.4. Children's Papulse Akrodmetrats [Janotti-Cross Syndrome]
L44.8. Other refined Papilloskamovy Changes
L44.9 Papilclamposic changes are unspecified

L45 * Papiloskamine disorders in diseases classified in other categories

Harfish and Erythema (L50-L54)

Excluded: Lyme Disease ( A69.2.)
Rosacea ( L71. -)

L50 Krapivnitsa

Excluded: Allergic contact dermatitis ( L23. -)
angioedema edema ( T78.3.)
hereditary vascular swelling ( E88.0.)
Sweep quinque ( T78.3.)
hives:
gigantic ( T78.3.)
newborn ( P83.8.)
papulse ( L28.2.)
pigment ( Q82.2.)
serum ( T80.6.)
sunny ( L56.3.)

L50.0. Allergic urticaria
L50.1. Idiopathic urticaria
L50.2. Urtilizer caused by the impact of low or high temperature
L50.3. Dermatographic urticaria
L50.4. Vibrating urticap
L50.5. Holieregic urticap
L50.6. Contact Uat
L50.8. Other urticaria
Hives:
chronic
periodic repeating
L50.9. Unspecified urticaria

L51 Erythema Multiforms

L51.0. Neboral erythema multiform
L51.1 Bullous erythema multiform. Stevens-Johnson Syndrome
L51.2. Toxic epidermal necroliz [Layella]
L51.8. Other erythema multiforms
L51.9. Erythema Multiform uncomfortable

L52 Erythema nodovaya

L53 Other erythematous states

Excluded: Erythema:
burn ( L59.0.)
arising from contact with the skin of external agents ( L23-L25)
owliness ( L30.4.)

L53.0. Toxic erythema
If necessary, identify the toxic substance uses an additional external cause code (class XX).
Excluded: Neonatal Toxic Erythema ( P83.1.)
L53.1 Erythema ring-shaped centrifugal
L53.2. Erythema Marginal
L53.3. Other chronic patterned erythema
L53.8. Other refined erythematous states
L53.9. The erythematous state is unspecified. Erythema BDU. Erythroderma

L54 * Erythema for diseases classified in other categories

L54.0.* Erythema marginal with acute articular rheumatism ( I00.+)
L54.8.* Erythema with other diseases classified in other categories

Skin disease and subcutaneous fiber,
Related radiation (L55-L59)

L55 Sunny Burn

L55.0. Sunny first-degree burn
L55.1. Sunny Burn of the Second Degree
L55.2. Sunny Burn of the third degree
L55.8. Other sunny burn
L55.9 Sunny burn uncomfortable

L56 Other sharp skin changes caused by ultraviolet radiation

L56.0. Medicinal phototoxic reaction
If necessary, identify the drug use additional external reasons (class XX).
L56.1. Dosage photo allergic reaction
If necessary, identify the drug use additional external reasons (class XX).
L56.2. Photofactful dermatitis
L56.3. Solar urticap
L56.4. Polymorphic light rash
L56.8. Other refined sharp skin changes caused by ultraviolet radiation
L56.9 Acute skin change caused by ultraviolet radiation, unspecified

L57 Skin Changes caused by chronic effects of non-ionizing radiation

L57.0. Actinic (photochemical) keratosis
Keratosis:
BDA
senile
solar
L57.1. Aktinic Reticuloid
L57.2. Rhombic skin on the back of the head (neck)
L57.3. Pihalodermia Sivatta
L57.4. Elder atrophy (lethargy) of the skin. Old elastosis
L57.5. Aktinic [Photochemical] Granuloma
L57.8. Other changes in skin caused by chronic effects of non-ionizing radiation
Farmer leather. Sail skin. Sunny dermatitis
L57.9 Changing the skin caused by chronic effects of non-ionizing radiation, unspecified

L58 radiation dermatitis radiation

L58.0. Acute radiation dermatitis
L58.1. Chronic radiation dermatitis
L58.9. Radiation dermatitis uncomfortable

L59 Other skin diseases and subcutaneous fiber associated with radiation

L59.0. Erythema Burning [Dermatitis AB IGNE]
L59.8. Other refined diseases of the skin and subcutaneous fiber associated with radiation
L59.9 Surface disease and subcutaneous fiber associated with radiation, unspecified

Diseases of skin appendages (L60-L75)

Excluded: congenital malformations of external covers ( Q84.. -)

L60 Nail Diseases

Excluded: Majo-shaped nails ( R68.3.)
Onyhia and paronychia ( L03.0.)

L60.0. Ingrown nail
L60.1. Onicholysis
L60.2. Onychogrif
L60.3. Distrophy nail
L60.4. Lines Bo.
L60.5. Yellow Nail Syndrome
L60.8. Other nail diseases
L60.9 Uncomfortable nail disease

L62 * Changes for nails during diseases classified in other categories

L62.0.* Bulavovoid nail with PahiderMapperity ( M89.4.+)
L62.8.* Nail changes in other diseases classified in other categories

L63 Nest Alopecia

L63.0. Alopecia Total
L63.1 Universal alopecia
L63.2. Nest baldness (belt shape)
L63.8. Other nest alopecia
L63.9. Nest alopecia uncomfortable

L64 Androgen alopecia

Included: Male type of baldness

L64.0. Androgen alopecia caused by drug intake
If necessary, identify the drug use additional external reasons (class XX).
L64.8. Other androgenic alopecia
L64.9. Androgen alopecia uncomfortable

L65 Other Uncoiling Hair Loss

Excluded: Trichothillary ( F63.3.)

L65.0. Telogenic loss of hair
L65.1 Anaged hair loss. Regenerating Miazma
L65.2. Alopecia Muzinosna
L65.8. Another refined uncoiling hair loss
L65.9 Uncomfortable Hair Loss Hair

L66 scarce alopecia

L66.0. Alopecia spotted scarceing
L66.1. Lained flat hair. Follicular flat lichen
L66.2. Folliculitis leading to baldness
L66.3. Peripolliculitis of the head Abscoting
L66.4. Folliculitis net scarning erythematous
L66.8. Other scarring alopecia
L66.9. Scarce alopecia uncomfortable

L67 Hair Color Anomalies and Hair Rod

Excluded: noded hair ( Q84.1.)
Hair besoids ( Q84.1.)
Telogenic hair loss ( L65.0.)

L67.0. Trichorexis nodular
L67.1. Changes in hair color. Sedina. Hands (premature). Heterochromia hair
Polyosis:
BDA
limited acquired
L67.8. Other hair color anomalies and hair rods. Lyubility of hair
L67.9 Abnormal Hair Color and Hair Rod Uncomfortable

L68 hypertrichosis

Included: Excessive Hair
Excluded: congenital hypertrichosis ( Q84.2.)
Sustainable powder hair ( Q84.2.)

L68.0. Girsutism
L68.1. Hypertrichoz powder hair acquired
If necessary, identify the drug that caused the violation, use the additional code of external causes (class XX).
L68.2. Localized hypertrichosis
L68.3. Polytricheia
L68.8. Another hypertrichosis
L68.9. Hyperitrihosis uncomfortable

L70 UGRI.

Excluded: Keloid Acne ( L73.0.)

L70.0. Ugrics Ordinary [ACNE VULGARIS]
L70.1. Acne Character
L70.2. Acne ospoovoid. Ugrics necrotic miliaria
L70.3. Tropical acne
L.70.4 Children's acne
L.70.5 ACNE Excoriee Des Jeunes Filles
L70.8. Other acne
L70.9. Unsurfaces

L71 Rosacea

L71.0. Periioral dermatitis
If necessary, identify drug Treatment, caused by defeat, use additional external reasons (class XX).
L71.1 Rynofima
L71.8. Another kind of rosacea
L71.9 Rosacea of \u200b\u200bunspecified view

L72 Follicular Cyers Skin and Subcutaneous Tissue

L72.0. Epidermal cyst
L72.1. Triphodermal cyst. Hair cyst. Kista Shan gland
L72.2. Stiatesistoma multiple
L72.8. Other follicular skin cysts and subcutaneous fiber
L72.9. Follicular cyst Skin and subcutaneous fiber uncomplicated

L73 Other Hair Follicles Diseases

L73.0. Acne keloid
{!LANG-218ff116e57864273b3cdde60f0400b3!}{!LANG-9c86e07e7935c3d8cc1b39c3dc78fd37!}
{!LANG-227fa8c4c9dabd4a5f7e007a28a6b78b!}{!LANG-104e3207104573fe7ccf381c74ea7788!}
{!LANG-a011e8037f210a173be372b8aaf4ef3d!}{!LANG-9bd94bb024b1389e3de0153dbc6a5ecd!}
{!LANG-7524e7c7bef9c80db31eec6910bdcdb2!}{!LANG-4b4520aed0960c3a5b46ea199992ed59!} {!LANG-f034f659548f05688c4675cd18160f83!}{!LANG-706caa19abe19463a68e2f99175e6333!}

{!LANG-79430ff7a367ed976eb9ecc336b15a93!}

{!LANG-821cc5f5b882ccb9f10c5dfbcb6fa7bb!} {!LANG-d1653c134047fcd4250eeac19b84ee19!}. -)

{!LANG-f1933678f5e408444b04845e8fd73b5b!}{!LANG-ecad98af58faa5cce494a36dccb517df!}
{!LANG-6485cc81b58336774d222f463538d9bf!}{!LANG-2ce49272213065b0b00b57460afd37d6!}
{!LANG-2d06144ee200464da74adab015813051!}{!LANG-3722341a8414fabd2ae90134d7ea3dab!}
{!LANG-44179384db5e902f699c969b0fb836f9!}{!LANG-7f8180b75ed51c54eb604a85add79360!}
{!LANG-eea947361c5912e27dde6d2f9fad7e71!}{!LANG-8646ecd6416c9bf30daf5eb42083f0a3!}
{!LANG-38c7deeeb4f935711f58fdf0e3ba8405!}{!LANG-07770c27f95dc04a976edbb5f21f4fc2!}
{!LANG-c7e88afb984e545e70dbe0ec5b08bc33!}{!LANG-db874bcbb3ae209246759df6a100abe0!}

{!LANG-19b214af54e46f603be64d54ddd21ceb!}

{!LANG-8dc9a3c1d534fc548548e63e4c9b6b0b!} L30.1.)
{!LANG-e0912f9913752619f5c8fd851358a419!} {!LANG-227fa8c4c9dabd4a5f7e007a28a6b78b!})

{!LANG-dda176428dbdb180f9ef7c17bd8d4224!}{!LANG-a1803ca123c586cb687c14361a245bc4!}
{!LANG-646309bb258a58d809986d39100ccafe!}{!LANG-981fb3c9652e6b200aba25e9866db03e!}
{!LANG-d4b04ca7daeabf26cb789c75d908c834!}{!LANG-54dc83bba74c215185a66b2fb7691650!}
{!LANG-d6d7b26663496122772815b334d0ca63!}{!LANG-45ab266877f76852c71a0696507912e6!}
{!LANG-4aaf935d3ac6209617f1568ff58a8060!}{!LANG-8a4dafc3476a0e07c99c7b109396fc34!}

{!LANG-70cef48691695c87fcbdbcf80989eb2b!}

{!LANG-799741f4d88a2550d7df691baee7a075!}

{!LANG-178b00bc6739236df9cba268ad0da172!}

{!LANG-6744d449e4730d9a55a0fde7611c0a69!} {!LANG-23ef81bfe5548cd26ddb8f2f1c06a79e!})
{!LANG-1663964f97a299d21a2c643a6cf38486!}
{!LANG-cd87d48f840e9c50427e1227c9d33019!} {!LANG-f4988038c029065712eec809f77ae6f5!})

{!LANG-ea1a755625006ff0c6c23d1d7233b6e0!}{!LANG-060ce7913573a7d5c0a176b993b97f15!}
{!LANG-b2ab920f93d968ef29ecc0eb86d92781!}{!LANG-b618e1a3f68c579d7685c9ea1bc334d2!}
{!LANG-de8f4fad84f68b791c9d8fade71a299e!}{!LANG-99133bffa087f79748ee429fc02e941d!}
L.81.3 {!LANG-d52dfe3583d3b20fcf19c3150201f5ea!}
L.81.4 {!LANG-70a13e16197fbb01f877068bb65fc5d7!}
{!LANG-6f65ea8bed0fd6fb87fb0ae92502e152!}{!LANG-8e13cbddde183857b837e46a6af46515!}
{!LANG-45e9d96b4308d375dd6f536688e21305!}{!LANG-18417f5cc015e1ce44c0f6dad5276865!}
{!LANG-7bb698e746303b7d0a51dc55db186223!}{!LANG-adff425b5fb63b78ded8435373d7ff3e!}
{!LANG-fdee11c754d6f32fc1ff000f2a8a42b1!}{!LANG-f78be4547bdd47d2af78ac7405faa622!}
{!LANG-8cb6be0962d2ad5e5ca7fe739cf98acf!}{!LANG-38a8600475b65bc5fc2bc9f8d5244956!}

{!LANG-3410fe93c11ec4d83050325e3f8b94c0!}

{!LANG-80632bd1c4b754aa61061d7d5f342396!}
{!LANG-4308516d6cf5df50fd684dcc77d8a285!}

{!LANG-181e7ad5459549100adba94ee1d81bbd!}

{!LANG-b7668d490ed80c77fa733e62e622c3ac!}

{!LANG-28b7e5251adaac68085523c8c0c97b3f!}

{!LANG-3b5782249791f2d3994fcdf50f684f1a!}
{!LANG-e8e6c92aaa069fb27ea4bf427ab8f097!}

{!LANG-6711ea255569b806cf49db6f8da63f8a!}

{!LANG-4e11458004ac6828a6a7fdf30d38ebcd!} {!LANG-00b080f500359276092f83d70e321f43!}. -)

{!LANG-31c2787da8575122688e7830981998d4!}{!LANG-553468c7b23c4b40a2e612df92d9ad8c!}
{!LANG-aed60af46dbe540dfd6ac0f42e650860!} {!LANG-28f51dfd18d12072a3d94bc893acb28e!}. -)
{!LANG-27cd89952015ef88e6dbc4af4c1d04ac!}{!LANG-76b63d87c7f499518c96b47b27069072!}
{!LANG-fad710734db9bb45064a6dc14577f1e2!} Q82.8.)
{!LANG-f1fb8fa7e2bec3849fb150d818697229!}{!LANG-1cc19b1c2039491a03d4f7060ff2ca02!}
L85.3.{!LANG-ddd81694891a1143ddcabe8e55bab96f!}
{!LANG-166ffcaa0e46d91cc5790003eb544888!}{!LANG-5a7720a7c0446f9e22f70f21a90891d5!}
{!LANG-8d6bd4c295784224c0673de130739ed6!}{!LANG-ccc53075aa266c7d65c8d475e16b7fb3!}

{!LANG-19d66425ff4f01d3b2e42f337459940f!}

{!LANG-4abd4173979bdb0ef872705b0a8badec!}
{!LANG-32c35df7bb1cfffbbb1eaf8f27c6bbfb!} {!LANG-62b68d59072dac88879082fb519858f8!}+)

{!LANG-3c8f17f5ff4bff5a801c2e84d508fd34!}

{!LANG-20bee43eae283e6e773a7fa8b85542f3!} {!LANG-831d9f62d309cd3dec282d59e15f4ce0!})

{!LANG-5149fe6a6f5e3fe090ed8374bd0418ae!}{!LANG-e177565b604e9a574ea962834d2fb676!}
{!LANG-821ed5afa3a37ccdc75c975d1bd20584!}
{!LANG-95f1175d35ecee6a2695830ce7634d5e!}{!LANG-b47027656369af8941f3059d1d2e4740!}
{!LANG-4bcfc58578ab6ddefb7eee97bd9389b1!}{!LANG-2ac7ee78820c39f3d32bf5be4f7dc6fd!}
{!LANG-e33ddaa76f48e0b7f261ca2025e0ce16!}{!LANG-d78c4e3fc5a38ba6fa00369bb0525c8b!}
{!LANG-bc1ae6fec981a7ea4ccb8f52720d0d30!}{!LANG-bb17e3e34e275b14c3191fc660599008!}

{!LANG-115949990374a398700df044edebf091!}

{!LANG-e9f0a12f78d527a9121c23115325562f!}
{!LANG-57ff4a8e27adf603cfa3e4f42ed5afb3!}

{!LANG-3aa0df630a73297d4daffed030e2b154!}

{!LANG-c3b5f37de2982972453dd33ac2585d67!}
{!LANG-fd478aa359d726f78a4237ffbfba8c14!}
{!LANG-3dc9478d06dc10ab53ad4ecc8cbe8321!}
{!LANG-a9686a3368114cba518f49765382a77b!} {!LANG-a7a3b01881ea91e70d464fa4f077b79d!})

{!LANG-7b6c539471da20ef2081ac20dab4d477!}

{!LANG-9bf9cd97558d75a8a49a64b023c9792b!}{!LANG-87ff362fb08d33e9df2edbcda28f9ce0!}
{!LANG-aa8e948e42322ed22747d6c6d0ab46d5!}{!LANG-144255610b83292532c97cc66541e890!}
{!LANG-2f866ebfc263527c3d2306540b07c08e!}{!LANG-eb01cfb98df413b16dba86297443cf07!}
{!LANG-cbb5f42b9ec2b6cd0414f2d1b9f05045!}{!LANG-3ec8c681d9e71829187e795694cfa172!}
{!LANG-c5589fd395ac5d43951ebe9de4b84771!}{!LANG-8bd079f4e8f872ec40e452baad63f4b2!}
{!LANG-4080d34ee493c2d363d9885a501bc5d1!}{!LANG-f4a3f76e13085975785cf4a2be0b72c7!}
{!LANG-4e598ed1bd2bdf97c0da4df72e665b91!} {!LANG-14a0fb278db3d4c80807cc7a44a51151!})
{!LANG-a1ace12c318a0ebe7b00ec4775a24707!} {!LANG-14a0fb278db3d4c80807cc7a44a51151!})
{!LANG-1f63548e235adab63bfaa15fbb609e2d!}{!LANG-e11abb3037e35ca73f53283b17f4acc9!}
{!LANG-8fe63a7acd0755cffaeac90dbdcdf363!}{!LANG-be637f9e94e3ae94f5803db31784a372!}
{!LANG-e5d3e612da1e01daa724e7ff5a3837fa!}{!LANG-508648402c391a0eb504a8e3b343cbb2!}

{!LANG-c8412b48c5bad5dca909adab242a2730!}

{!LANG-14a0fb278db3d4c80807cc7a44a51151!} {!LANG-d3f4deca906d38651b5157ef8e6c41e2!}{!LANG-d8f6488ff1d5f38259f7c61b65aa45f6!}
{!LANG-14cbcbd880d9218c8e366a2b732896fb!} L73.0.)
{!LANG-80a29e4dab2b745ee6ed83b70b21a130!} {!LANG-4080d34ee493c2d363d9885a501bc5d1!})
{!LANG-1798c074e87a7f5cdde611968c3b38fe!}{!LANG-7cd57b14f142dd6049f09afbcf1bce97!}
{!LANG-1362559423e19c20b756ae65a958c0cd!}{!LANG-e7aff16bff6c05ba572f86df6c6256eb!}

{!LANG-41ab37b96a06c45d1bf0d1f44754770c!}

{!LANG-302f30fd888d0311af2e2f7bb79aa2c6!} L57.5.)

{!LANG-831d9f62d309cd3dec282d59e15f4ce0!}{!LANG-98b7edeb2894b640ddf3017b53583655!}
{!LANG-dd18e77041bafd26b8f78f254c09aaf3!}{!LANG-591f0479f7c3b1d6110b5022378b9a50!}
{!LANG-b0abec3ed2795c3520150fcd5d92447d!} {!LANG-eb5b4433a2d2cda0e2af53264f91db9b!}-{!LANG-94b197a40d10431caf6d24a3dcec2f8d!})
{!LANG-d833e26e33b756cc09751a6c641775a0!}{!LANG-5fa67368a3b12a7ce29f2cbf9bd01629!}
{!LANG-6933b43c3ceb0eb8aa0ced9f22475b0d!}{!LANG-2e05a5765d5949bf3df0a45da3399354!}
{!LANG-a467bbd8cce7334a1b8d6171aae9d33b!}{!LANG-019d429e6788164395766668efc5617c!}
{!LANG-42592794dd3aedfb8a2689495275748f!}{!LANG-976490da7995518852330a04e424621a!}

{!LANG-e307f684fe7fd26553e4ed24e1e46501!}

{!LANG-ddaf81fc8dcf45d75bef3547572e452e!}
{!LANG-aa13cff2775cd4f0fbf064927eb37865!} {!LANG-6a5a8ec33bbde224fadb7548bacce7a4!})
{!LANG-fe4e5480d431b99366ebea523cc7f292!} {!LANG-6a5a8ec33bbde224fadb7548bacce7a4!})
{!LANG-723d1439345371868488521148a30856!} {!LANG-f6aae1483fd787f37bbd305a57dc6278!}. -)
{!LANG-bf752f567832fed19b1062660d043147!} {!LANG-0e2ebce60d896da3a5bcde6c4c514ff6!}. -)
{!LANG-52f8688d4bdb38ab8b8813a5f750f567!}
{!LANG-5a366d540078daec3652e177f7dd9bac!}{!LANG-b0b2fb06c2fdd7c2442e284dc741e4ed!}
{!LANG-3fb61c10ec8c43c1b6fa32bb657d7485!}{!LANG-3801272b13fadbe87dac158939b20b56!}
L93.2.{!LANG-38a213206ed759edaa96b3f42149f112!}

{!LANG-056972b8029077bfde2858c8fde39097!}

{!LANG-f417fbd19a6e2ff88006fc8d39a1b5cd!} {!LANG-2d3ba1a92710a7c22d0a665391a94d3c!}-{!LANG-4543007e47382b27f33330975a20fd36!})

{!LANG-7a645c88fa952501041c46d46a69f72d!}{!LANG-d11884d5d94981e7fc65f0f234432250!}
{!LANG-1bff483a15375fdd14402a2a3d89f000!}{!LANG-a90b022f9104eedf3f4e5c391b226f18!}
{!LANG-1c9b619a282e8810e1b1eb9533ea6485!}{!LANG-9b2aa3d1d35ed970137956e15e56bad2!}
{!LANG-1fef913f8e919aaec8929fe87c40e477!}{!LANG-45d61017555ca506c65ce4fe1bbe57ef!}
{!LANG-f9c3f1338dbb7152edbaa768d8586054!}{!LANG-f6d2864b99f5e02f5b4fc22b44e93d32!}
L94.5.{!LANG-b5ea5112ebd9d2db11a603b2925fdd46!}
{!LANG-28b13caebea33c50cab4d386e2a54d6b!}{!LANG-64ea3ec438557b0ee1cd5af512ce1384!}
{!LANG-6508a5382c524bb51135763c32e45839!}{!LANG-fcaeececd6debb56f27b0bfbac96115d!}
{!LANG-72475ce0cfa592b9b704df362939c9c1!}{!LANG-4458e7b9507015d6988aea2ddb305369!}

{!LANG-ca266a29968bf92d0e90de772b907eec!}

{!LANG-e2bf4349e2665d0ca2a194db3f562667!} {!LANG-7bb698e746303b7d0a51dc55db186223!})
{!LANG-ff4b602f544c6ef772145f1f27dcb8eb!} {!LANG-d6af1c64755d736e30213c49a4e64353!})
{!LANG-d28bf55329f758430889200438249555!} {!LANG-599835f201e440b2e8ddf833e03a5614!})
Pannaculit:
BDU ( M79.3.)
lupus ( L93.2.)
neck and backs ( M54.0.)
{!LANG-cb119bbf52afe3c5a731ac1d3b511e47!} M35.6.)
{!LANG-2a1f3c734315c3b0ac6cf28129ee41ed!} {!LANG-aabc4d8d503460b77161bbc20a944e32!})
{!LANG-f4b8a6d8ee06d620f4e140038e52cd98!} {!LANG-a686fb64f0251ca774c2ac9383beb1bf!})
{!LANG-e6d8eafc6736f798cce5d1cf1871de0b!} T80.6.)
Urban ( L50.. -)
{!LANG-e573565201edfd9965e3c1744ade8b4b!} {!LANG-2d1042b7b03b6369f6655b8c36a7e6d6!})

{!LANG-776e6182d275cd211a4fb7add3ab8bf9!}{!LANG-47a06d6f5042452217690934dd77f17a!}
{!LANG-6ca2f500e530c9c63785cbdf244e011b!}{!LANG-48b7a12c6d49d15201364675e305f94f!}
{!LANG-4f7e35675891a4a0059ebd9350357c2b!}{!LANG-0ae399f152bbd65780bc01dff0759ebe!}
{!LANG-ab3a4f78e0b0703578ab4c375d825dbf!}{!LANG-1d10450a2463078440cf574083d80f66!}

{!LANG-6f0d541fffc151d61ae4ef730f3155bb!}

{!LANG-238fa129a6891e1cee1bf003ce714fb7!})
{!LANG-9a725ea9ea447a2cc6aff5830f2f10d0!} {!LANG-a3f8915ad21e5ed02bbf15cb11a5ecee!})
{!LANG-d338fa99492bfcbf93f77f6f943ab85e!} L00.-{!LANG-d322f494373a4eae141f6257c5907698!})
{!LANG-591124ca16b774f7b76788f39295797c!}-{!LANG-30cf3d7d133b08543cb6c8933c29dfd7!}99
{!LANG-d02d2179449218ae3838e20b75bff7bb!} I.83.0 , I.83.2 )

{!LANG-40614806119bb14d60dadb61aed4d894!}

L98.0.{!LANG-3dc7558ff8f436750549e9948bac8e93!}
L98.1{!LANG-a0daf1c4d1f28881eb746c1ccf3c811f!}
L98.2.{!LANG-8131c20f6d7d34ee23255249a6360852!}
L98.3.{!LANG-9c9a641dbea270c5f5bd560f602372ee!}
{!LANG-f52dce9c8b4fe1ed31650dfda571ca28!}{!LANG-9dffe018d4329e7728f515e7a46f2818!}
{!LANG-9eeb8f87c0226eb21d2a572fa4a7b423!}
{!LANG-8964312d8f3f27b701f88e5e2e9520db!} {!LANG-238fa129a6891e1cee1bf003ce714fb7!})
{!LANG-9a725ea9ea447a2cc6aff5830f2f10d0!} {!LANG-a3f8915ad21e5ed02bbf15cb11a5ecee!})
{!LANG-d338fa99492bfcbf93f77f6f943ab85e!} L00.-{!LANG-d322f494373a4eae141f6257c5907698!})
{!LANG-8e9d9528af8417f658f1f7098290d6db!} {!LANG-c71d184f2642233ec95d0c2f4d41bc97!}-{!LANG-d719839c09593196c62f3fe027547216!}
{!LANG-f7fd31fa1e136948e4925b78f1cb3eb8!} {!LANG-bf032d931c82924f4e691daca34bb825!})
{!LANG-d02d2179449218ae3838e20b75bff7bb!} I.83.0 , I.83.2 )
{!LANG-f42d97388582f45cbbb77bbb08a0b152!}{!LANG-31fb099373620b0213fa27f3e0b7eb38!}
{!LANG-bc54cacfb93454c7fd010c2874ddc8cc!} {!LANG-e1e20bd364948272bb5b3edc1cf7c4a4!})
{!LANG-04cfe2055d8b8eba94ea08874164c29c!} {!LANG-d805060c275068ec09020237f9364fad!})
{!LANG-36d33070ca3812c6dadf579565cefb61!}{!LANG-adff41bf63f3f80e9d146b746ea327a6!}
{!LANG-89c88d2e0bf3cee8dde3ab190a518674!} {!LANG-598e3a15ca87a72b241d6942099f61e7!})
{!LANG-edfce85251f8a0a2c992b1248530192a!}{!LANG-671cd68e928840c37546d09114f1dcf6!}
{!LANG-5812d15d62341de240df5841b3fc58d3!}{!LANG-5ee788338513786b5a5068c98d1e866d!}

{!LANG-7a65e65daf1f10fbc3e266482a21fa40!}

{!LANG-7d3df4084f1bd166c4f0f107a1643cd9!}{!LANG-b21308218cec4fb0ebe69e407da65c31!} {!LANG-a5c28610e121a876319d4ee8235b131b!}. -+)
{!LANG-7d426d939bfb97c5c69acebb71bcbdb7!}
{!LANG-cab2a556b413b86b026338f74754bb69!}{!LANG-daf9fe3e5dc113ebadc0026a362fcbfe!}
{!LANG-e63edd03866e0e3c4f80eec99f96de09!}
{!LANG-72dfedcd686fd7b5b4b863983eba1846!} {!LANG-5eec892716ae16d1024f3e85abd8fac7!}+)
{!LANG-43c41b4d6d0ad5bb098c4d541144bf06!} {!LANG-5eec892716ae16d1024f3e85abd8fac7!}+, {!LANG-8d014d88e4d37b221511db7110119bb1!}+)

{!LANG-c76f27ca4fa0f521bc6808ed96b26a2c!}

{!LANG-d712c95a7c92b770fc1d17a069a1964f!} {!LANG-26bcd2af349df391ad570e3cfa1c4d5b!}{!LANG-7074819b38cbbd29d53e1deb253d9f8d!}

{!LANG-4b85afaba315672808823dd9fcdd0fc0!}

{!LANG-7fd83751b9873eebb02ffdc180df76fc!}
{!LANG-0bfa3eebf664982de9d4be57c14f20e4!}
{!LANG-53a09cdad52af464f02ce28424aca1ff!}
{!LANG-bd978839b310df83166fec55f36882d3!}

{!LANG-a7b7b0863c1fa337716e5b73083024a7!}

{!LANG-c6f78479c488501b5c082af74f81a486!}

{!LANG-9a1fd1d081ce9f32906933e76741ed2c!}

{!LANG-bd3762da953ec0d60c6df1e4d71cb7c0!}

{!LANG-9a1e9490cd599ad80c3b0305794416da!}

{!LANG-3e8f71f33ff8b7de71eb18f3de5868cc!}

{!LANG-cbe2f1fb4632e83e9144ffeba4a90dc4!}
{!LANG-15afa868fd915711e0ad65d9f4ec8bd1!}
{!LANG-311b57099cb15a3f92deb5c38e8ab310!}
{!LANG-c344013589cf788e32fedb73dc910d7d!} {!LANG-cdbb008432b37496383dffa03b516b20!}.
{!LANG-5b00f5c3be6537cb8daa56d765d8ea2e!}
{!LANG-992d1e440adb831200c7d1dab27ede4d!}
{!LANG-aac7337e0d3b93833b5bcda9b3e921dd!}
{!LANG-f150856bfa742726eb2785a115fe8399!}.
{!LANG-3f70b6d62d03aeedd163f84948750d0b!}
{!LANG-de2adca0ef0cad1bf5a8b2af17d352c3!}
{!LANG-5f91e44dac27a8a45eb57568742be32d!}
{!LANG-c759fe30fb784c3c2b5776f4db5838af!}
{!LANG-45eefa3f71dbfa367d1230128288690c!}

{!LANG-f7c2e68fdb8dac3bfd56f4539d9a8fdc!}

{!LANG-480f6803b9da24628029219424ee0054!}

{!LANG-105bbfc789b0d1f7f72f0fae79b370b1!}

{!LANG-a1b81cc9837ef3582df4a7fe22b2cd19!}
{!LANG-a9b215a640500accd53da99d94f931fb!}
{!LANG-6897a80f0f46e78f0e0b05c399155ae2!} {!LANG-3c29d1e0ce3284b539259955fa749d91!}{!LANG-38bd148c325c4646f713e8bccb8cad47!}

{!LANG-44a9379e7fe46cf6eb94091deade06de!}

{!LANG-de2e241083ab8ea4112aaf42a2c16dd7!}

{!LANG-dae6eb80dfa969e4596bf4215cc94a52!}

{!LANG-76a020cd30224b9836c10d25ffa6cf35!}

{!LANG-be8abd9f1a19639659eb529ac0bf6406!}

{!LANG-0cd2e3e8b9c520722a90e8210c4e8170!}

{!LANG-5d69e26fa19fe7bb324cfe7ebb10f32c!} {!LANG-ec0bd1e6f019ac2ec810de54ff0b6616!}:

{!LANG-1fdb5aec1b569db478771a246bb2d720!}
{!LANG-aff7c26eee1dc49d543b272eebcc19ef!}
{!LANG-9dcaf668a0824e01c5200f9a88bd6a74!}
{!LANG-65a17f4c1ab0f9b8dcae577a02bec62d!} {!LANG-4214a9a013a6797c8cdea9775cd84bc1!}{!LANG-5585d6d33a7ece226525fc9295b242cd!}
{!LANG-384510f86fc7a31842ec3ebe8bf1a4c0!}
{!LANG-5bbe7aed3d28e2f78a52678c39581624!}
{!LANG-1db1b4c53ec63fc026363df5e69e1c54!}

{!LANG-d02ae726371dae379566d4fe9dd46118!}

{!LANG-afa296f1358c3e8c16de152d2fd93293!}

{!LANG-11f9801e327c850995cb28797fc335f7!}

{!LANG-5d3f0c816f70fa51a4324d34ea4aa690!}

{!LANG-08bfb5d271c7d411ff6628637c016a6a!}
{!LANG-7150afcbaff141f4708665cdbe12443c!}
{!LANG-9a0dc93d7ff9f76de3c34c3e52e9050e!} {!LANG-f1021ba1467959e0a00939d159bda613!}{!LANG-1eafea7fed8194f63b1015785d8b33fe!}
{!LANG-57ec5c657a9410cc9b6774aa0e17c160!} {!LANG-ad7182f4306f8057ab994d195858db02!}{!LANG-ea7bef8b9686e317e4d99584c2d21b22!} {!LANG-8c54a6a6a079c39fba0738789752c8a0!};
{!LANG-0415de34f0951e4a60fbedc44e7af97e!}
{!LANG-497f3956096f3eae550ea6505aff85e9!}
{!LANG-d7e5e5f41c40569c2f18f8c9a7fe6fab!}
{!LANG-c0bfe09b2502b0cf97d0187f802883f0!}

{!LANG-81c5600b47af3942f6f33b9e1563e85d!}

{!LANG-bbba60b80374ef8ff6a2fdf9bbb30825!}

{!LANG-ac8f6996ae942cbabb8458617d29ff2f!}

{!LANG-d1670bebb17689fe726b033ecbe2a0f7!}

{!LANG-f236cd5f33642332129ff1c0bdab2163!}

{!LANG-13feecc0279685a23f8f2b03d87ce8a2!}

{!LANG-2dbc4e3680049a927930528b68e43719!}
{!LANG-aa45f604e693dd366c5905b604182cab!}
{!LANG-051ccff7de0a84bf3cb7b3e1404409d7!}

{!LANG-11030af69941f3f75c970736afb30ed1!}

{!LANG-9cca33e5ff71eee3ddd86a5b6b219875!}

{!LANG-0b3552ee4da445bb729eea8997f0c36e!}

{!LANG-9258c179b882296f4dc948e119294bcb!}

{!LANG-f6dcbaafb4f8ef62c3aa93065f2d72e9!} {!LANG-8d8b76d2dd1c57d07da2ff59390ec6c2!}{!LANG-060fd29858f3a3992281659d13fcab10!}

{!LANG-cc3a97a4753780af7c06b58351e4115d!}

{!LANG-1f822698731e77171f68388e8c04f07d!} {!LANG-244cd3eedb6097ded4ac9510517663ec!}{!LANG-d1ff6189aae776a23751c8f081d19ed8!}

{!LANG-aad65518ba1b829c0f3d622ead95ccf6!}

{!LANG-7698590eb96651b6927cd028f3fdf12f!}

{!LANG-dc407a8be19ddfb34377901c6961436e!}

{!LANG-be6312401ae2a202fe3809303ef03f03!}
{!LANG-95303855793cb5d0cc06775785f16f45!}
{!LANG-71f552314ba620f747c24bc1e851f87e!}
{!LANG-cb302f5c6dd761a9329703fd391ba422!}

{!LANG-9bd70c2a440988446d845e1ebc140ddb!} {!LANG-fb90ee797947de441462b08e381e8bd9!}{!LANG-7ce5dd18e33b7e6af438d33297ba6b1c!}

{!LANG-17620642c4742e85902c480f08a12601!}

{!LANG-dc45234a426d0b1bdaa1bbe47c93cfa0!}

{!LANG-bfa0410e313d493f66ac17e4e9725f67!}

{!LANG-5fa33a8b76b9e4cadbc779d491832de7!}

{!LANG-85c19f4f86a405325400aa2c2c4bbeef!}
{!LANG-e5347fcf80318f028e0de9dfd2a08368!}

{!LANG-897a7bceb6124cf734e617c86cce4104!} {!LANG-9af819ac0feaecb13216987dd2d3ed07!}{!LANG-488d90b1f5f10fd0b6dca492077b2afc!}

{!LANG-af28810d8ca51dd93d4626093eeb2b2c!}

{!LANG-bbf9b5a7ec5fd952b24554e85244346e!}

{!LANG-1540646207eb1fc742921e4b285e636e!}

{!LANG-9610d20dee3dd5b1ae703af4f0c0ec6a!}
{!LANG-e981056d2d4bef8baeb14f1e1ec7f257!}
{!LANG-b2a4faa22543744d1d3929071f0a8bce!}

{!LANG-a76ce13c0b964a840c9bfc4eeab5edbd!}

{!LANG-2c0b1d42337f25cdec01cb76815479d4!}

{!LANG-32fb4c13a0358464e26d10f81edaee32!}
{!LANG-9acbab127e694669d8e538a7a7b4e3fe!}
{!LANG-aad46411cdf4f7ed86ba3130f78e7d5f!}
{!LANG-43fa84686f52fbf41127e64ff473835e!}
{!LANG-11d78e746d7d83e097a545a214787fdf!}
{!LANG-3659e1afc48b01304143f8eb7fe83f44!}

{!LANG-0df4e1bbc904887e72f406df65272d86!}

{!LANG-6180b7a0402b70de6d78b5f7b4949dec!} {!LANG-64efe9601a7960c5b52a0ba13d6a5ecc!}{!LANG-268f186b427a9c480211211c53c07159!}

{!LANG-6fe14d16f9f1ae4990b0f229c5f424e3!}

{!LANG-5a819ab3e3adc305af99c11c6b9118e9!}

{!LANG-3bdcae54b07c7771a38353d63a19ad0b!} {!LANG-dd30edfcf27bc28e672c1bda3f5c931e!}{!LANG-771dec084ba110226a5bdd5f4000d864!}

{!LANG-a3b2e6670d23b7f69b52049295f884f3!}

{!LANG-df90bfc04d895bf5e5ec71e7c9d2a888!}

{!LANG-cfa314196074956a4cc240d8f3672c96!}

{!LANG-05d258db091cf0d5bc5bd7f38289793f!}
{!LANG-8bb57dbb1fddfd2700e1eb4a4492c667!}
{!LANG-4f16bc67cbc1be1fe7e17259fa9ec8c6!}
{!LANG-e870d91fd8cca525769a6f63256c0f20!}
{!LANG-0cedad407fe62477efccfa17871196a8!}
{!LANG-f099eb61c28c62754a7bafd5be200914!}
{!LANG-ae9569a48b273980a0cdca4b6ef04878!}
diabetes;
{!LANG-d40de5c33aa7fbd641c483fc40def65d!}
{!LANG-5d206fbca31d2b9dc440c532107ec33b!}

{!LANG-372e171df5f094762893484c85bc96a5!}

{!LANG-d9c78c32053d97ca3fb538beefefb7a1!}

{!LANG-34e54a0a16c30c14a19891b61bfabc96!} {!LANG-59894bf6821574774343ef7745f7c6d8!}{!LANG-4be0d3617a88cec599593518432c6ded!}

{!LANG-cf01dea012d0d7f87ae2285047a33663!}
{!LANG-b154792ad476f5b0455876b874414009!}
{!LANG-b50fee136eef193c3d035ce74c45254a!}
{!LANG-28df0b0ba0fdeb7afe27d37a0707e808!}
{!LANG-4807b5f188b75e54490a27d9de694384!}
{!LANG-217c66d20d4f70b901152f125e2eb0be!}
{!LANG-92c77bfae92027e9f022266c1c0e9870!}
{!LANG-0cdbb0530d6b1782c0ead9b51a80f6b5!}
{!LANG-79f120586f10cd3188891f85c839903e!}

{!LANG-356c82195bd7410c051198d9a4340c9c!}

{!LANG-798f67922e3f35fd965e549cd0310ec9!}

{!LANG-f3af73d6fd81b2d068245c9a750c57f1!}

{!LANG-c12fcccfe8c3cc896dec49660c4a0022!}
{!LANG-fa657cef5c26c34e2ecfe9e6de0b79fa!}
{!LANG-051511bceccf9cd45b7c9c71f9d1c2e9!}
{!LANG-3466f207113dc0ef34d6106843b76853!}

{!LANG-9ead84c0b0ee4712c860dd31e12a38b1!}

{!LANG-eda4f013a5eb3f4919969568b3cff77f!}

{!LANG-f1e7dfa22409bea4991bd4293ed30ff1!}

{!LANG-0cc62d66d561c8bd1a0c12193a4dda81!}
{!LANG-ab6e226359bd5be597ca3e41aaf24b46!}
{!LANG-09a9d77a79f51e3c300ec8bf3af4709a!}
{!LANG-ea8dd09ef17740cb733cb4ae759a7344!}

{!LANG-9d58a7034222c6e0b5f4f6c71b7d4f81!}

{!LANG-10d3680263d8431af4edd10574ff115e!}
{!LANG-fdf5e77864c79d33c0df2cc9f8eb3c16!}
{!LANG-08d78df0d7ffb2cf5329a16ca4ecc09c!}
{!LANG-e497030b22f236af45312278df8cfa89!}
{!LANG-0d8bef8332dee2db0a2d6eaafffba7fe!} {!LANG-9eea1cb837ab0031919fbd09e9f68c4c!}{!LANG-314c0ad99b5ba7db14f4794857ed82f6!}

{!LANG-737d58c04efef282437e1238165bbe46!} {!LANG-8f641e08b24b79cdf7242c5dd4565704!}{!LANG-f8bef466ccaf8be735cd2126fb28a008!}

{!LANG-8c8c1b3af1c7adb017f9b101b4f76d05!}